Skip to content

Released Mar 28, 2013, during market hours

10-K filed Mar 28, 2013, 87 days after period end · 0001144204-13-018178

Q4 2012 · 10-K
Revenue$9.08M+21.7% vs Q4 2011+67.7% vs Q3 2012
Net Income$453.00KN/M vs Q4 2011−57.8% vs Q3 2012
EPS Diluted$0.04no prior Q4 2011 on file−42.9% vs Q3 2012
Gross Profit$5,688,000+18.6%
Operating Incomederived$451,000N/M
Operating Cash Flowderived-$2,336,000N/M
Free Cash Flowderived-$2,313,000N/M
Margins · derived
Gross margin62.7%−1.6 pt vs Q4 2011
Operating margin5.0%+29.6 pt vs Q4 2011
Net margin5.0%+29.5 pt vs Q4 2011

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-K.

Same quarter

MetricQ4 2012Q4 2011derived from reported figuresQ4 2010derived from reported figures
Revenue$9.08M$7.46M—
Net Income$453.00K-$1.83M—
EPS Diluted$0.04——

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

ProPhase Labs, Inc. · CIK 868278 · Engraved from SEC EDGAR